Cargando…

Consenso multidisciplinar para el seguimiento y control del asma mediante la telemedicina. El proyecto COMETA

Despite the therapeutic advances currently available, asthma control is poor. Such control is based on assessing the patient, adjusting treatment, and reviewing the response to treatment. In normal situations, asthma is monitored and controlled by sequential face-to-face visits. However, due to bios...

Descripción completa

Detalles Bibliográficos
Autores principales: Almonacid Sánchez, Carlos, Blanco Aparicio, Marina, Domínguez Ortega, Javier, Giner Donaire, Jordi, Molina Paris, Jesús, Sánchez Marcos, Navidad, Plaza, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369603/
https://www.ncbi.nlm.nih.gov/pubmed/37497073
http://dx.doi.org/10.1016/j.opresp.2021.100098
Descripción
Sumario:Despite the therapeutic advances currently available, asthma control is poor. Such control is based on assessing the patient, adjusting treatment, and reviewing the response to treatment. In normal situations, asthma is monitored and controlled by sequential face-to-face visits. However, due to biosecurity and distancing measures to avoid disease transmission during a pandemic, such monitoring and control is limited. This is how tele-assistance, which is available from extensive published evidence in asthma, has emerged. Even so, it should not be understood as a substitute for face-to-face consultations, but as a complementary alternative to them, in which patients can be monitored when a face-to-face consultation is not necessary or cannot be carried out. Through the COMETA project (COntrol como Meta en la Era de la Telemedicina en el Asma, Control as a Goal in the Age of Telemedicine in Asthma), a group of experts addressed in depth the asthmatic pathology, analyzing in detail the existing problems in order to achieve control and propose solutions to situations such as those we are currently experiencing with the COVID-19 pandemic.